Syndax Pharmaceuticals SNDX Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Syndax Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The official record: Syndax Pharmaceuticals’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Syndax Pharmaceuticals's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Syndax Pharmaceuticals's current ratio?
- Syndax Pharmaceuticals (SNDX) reported current ratio of 5.5× in Q1 2026.
- How has Syndax Pharmaceuticals's current ratio changed year-over-year?
- Syndax Pharmaceuticals's current ratio decreased by 5.8% year-over-year, from 5.8× to 5.5×.
- What is the long-term trend for Syndax Pharmaceuticals's current ratio?
- Over 5 years (2020 to 2025), Syndax Pharmaceuticals's current ratio has grown at a -22.6% compound annual growth rate (CAGR), from 15.8× to 4.4×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.